Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PSMA617-TCMC is a derivative of PSMA-617 with structure modification, in which the caroboxy groups in DOTA ring is replaced by TCMC macrocycle. PSMA-617 is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer.
説明 | PSMA617-TCMC is a derivative of PSMA-617 with structure modification, in which the caroboxy groups in DOTA ring is replaced by TCMC macrocycle. PSMA-617 is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. |
別名 | PSMA617-TCMC TFA salt, PSMA617-analog, PSMA617-derivative with TCMC, PSMA-617-TCMC |
分子量 | 1659.52 |
分子式 | C65H86F12N14O21S |
CAS No. | 2937423-47-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PSMA617-TCMC TFA 2937423-47-5 PSMA-617-TCMC TFA PSMA617-TCMC TFA salt PSMA617-analog, PSMA617-derivative with TCMC PSMA-617-TCMC PSMA617TCMC TFA PSMA617 TCMC TFA Inhibitor inhibitor inhibit